Complete this follow-up survey to help us measure the impact of our program on your practice. Please share an example of how this program influenced your practice and/or research. Do you believe your participation in this activity has… * DefinitelyVery likelyPossiblyUnlikelyNot at allNA Led to practice improvements Led to practice improvements - Definitely Led to practice improvements - Very likely Led to practice improvements - Possibly Led to practice improvements - Unlikely Led to practice improvements - Not at all Led to practice improvements - NA Led to patient benefits Led to patient benefits - Definitely Led to patient benefits - Very likely Led to patient benefits - Possibly Led to patient benefits - Unlikely Led to patient benefits - Not at all Led to patient benefits - NA What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. * Improved recognition of signs and symptoms Improved selection of diagnostic tests Improved interpretation of diagnostic tests Increased screening of high-risk individuals Updated my knowledge of available formulations Individualized patient care using new therapies This activity confirmed my practice Not in practice Other... What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. * Earlier intervention Better understanding of disease Better understanding of therapy options Improved therapy application and adherence Improved quality of life Comorbidity prevention No patient benefit Not in practice Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. Other... Which of the following barriers have prevented you from optimally screening and treating patients with androgen deficiency? Select all that apply. * Cost of therapy Difficulty identifying high-risk individuals Difficulty identifying features Difficulty assessing potential benefits of therapy Pre-existing conditions Lack of familiarity with newer formulations Limited safety information Not in practice Other... Which of the following barriers have prevented you from optimally screening and treating patients with androgen deficiency? Select all that apply. Other... Please share any additional feedback you have about the program. Leave this field blank
